Preventing Obstetric Complications With Dietary Intervention (PLATE)

March 13, 2024 updated by: Anna Palatnik, MD, Medical College of Wisconsin

Preventing Common Obstetric Complications Through an Immersive, Medically Tailored Meal Program

The goal of this study is to learn whether access to healthy and fresh food, health coaching, and nutrition support intervention can reduce adverse birth outcomes in pregnant women. The main questions it aims to answer are:

  • Does access to healthy and fresh food, health coaching and nutrition support reduce the risk of gestational diabetes or preeclampsia and ultimately improve health outcomes for mothers and their newborns?
  • Are participants able to successfully utilize the health program? Are participants satisfied and self-equipped to apply the teachings of the program within their lives following their participation in the study? Participants will be randomly assigned to one of two groups.

Participants in the standard of care will be asked to:

  • Complete surveys
  • Biometric screenings

Participants in the intervention group will be asked to:

  • Complete surveys
  • Biometric screenings
  • Participate in weekly personal health coaching
  • Receive and consume provided weekly meals.

Researchers will compare the standard of care to those who receive the intervention to see the impact of the intervention on clinical outcomes including: gestational weight gain, blood pressure, diagnosis of gestational diabetes, diagnosis of gestational hypertension or preeclampsia, and gestational age at birth.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion criteria:

  1. Age at enrollment ≥ 18 years of age
  2. Receiving prenatal care at Froedtert
  3. ≤ 16 weeks and 6 days of gestation
  4. At risk of preeclampsia, defined as being eligible for low dose aspirin treatment AND/OR at risk for gestational diabetes defined as having a history of gestational diabetes, OR previously given birth to an infant weighing ≥ 4000 g, OR has a diagnosis of PCOS
  5. Pre-pregnancy Body Mass Index ≥ 25 kg/m^2
  6. Resides in Milwaukee County at time of consent
  7. Low socio-economic status (<200% of FPL defined as receiving Medicaid)
  8. Able to read and communicate in English
  9. Has access to a smart device/computer with reliable internet connection
  10. Has access to a working refrigerator
  11. Viable singleton pregnancy

Exclusion criteria:

  1. Diagnosed with Type I or Type II Diabetes or Hemoglobin A1C ≥ 6.5%
  2. Diagnosed with End Stage Renal Disease
  3. Use of weight-increasing psychotropic agents
  4. Active inflammatory bowel disease, or history of bowel resection or malabsorptive syndrome, or history of bariatric surgery
  5. Significant food allergies, preferences or dietary requirements that would interfere with diet adherence
  6. Multifetal gestation
  7. Active substance use that would preclude program adherence
  8. Chronic use of oral corticosteroids
  9. Unable to provide informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Standard Prenatal Care
Standard Prenatal Care, biometric screenings, and surveys (baseline, 4-12 weeks postpartum).
Experimental: Maternal Health Management Program
Program participants will receive 10 fresh, local meals each week, delivered to their homes, health coaching including cooking and physical activity, biometrics screenings, and educational support to enable sustainable lifestyle change.
Program participants will receive 10 fresh, local meals each week, delivered to their homes, health coaching including cooking and physical activity, biometrics screenings, and educational support to enable sustainable lifestyle change.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical Outcomes
Time Frame: End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
gestational weight gain (BMI early pregnancy in comparison to BMI at delivery)
End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
Clinical Outcomes
Time Frame: End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
blood pressure (Compared to early pregnancy, intrapartum, postpartum
End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
Clinical Outcomes
Time Frame: End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
Diagnosis of gestational diabetes
End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
Clinical Outcomes
Time Frame: End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
Diagnosis of preeclampsia or gestational hypertension
End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
Clinical Outcomes
Time Frame: End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
Gestational age at birth (Weeks and Days)
End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Reported Outcomes
Time Frame: End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
program utilization (measured by percentage of weekly coaching attended and number of meals consumed)
End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
Patient Reported Outcomes
Time Frame: End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
participant satisfaction and retention (measured by end of study evaluation)
End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
Patient Reported Outcomes
Time Frame: End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
self-efficacy skills with meals preparation (as measured by nutrition survey)
End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
Patient Reported Outcomes
Time Frame: End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
physical activity planning (as measured by physical activity survey)
End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
Patient Reported Outcomes
Time Frame: End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)
Self-Efficacy (as measure by Self-Efficacy survey)
End of Pregnancy up to 8 weeks postpartum (+/- 2 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Anna Palatnik, MD, Medical College of Wisconsin

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 1, 2024

Primary Completion (Estimated)

June 30, 2025

Study Completion (Estimated)

August 31, 2025

Study Registration Dates

First Submitted

March 5, 2024

First Submitted That Met QC Criteria

March 13, 2024

First Posted (Actual)

March 20, 2024

Study Record Updates

Last Update Posted (Actual)

March 20, 2024

Last Update Submitted That Met QC Criteria

March 13, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Preeclampsia

Clinical Trials on Maternal Health Management Program

3
Subscribe